Saturday, July 18, 2026
The UPSC Times
THe Upsc Times

“A nation thinks through its readers.”

ADVERTISEMENT

India’s biosecurity gap in the age of new biotechnology

New biotech lowers barriers to misuse of pathogens; India needs a unified biosecurity framework across labs, health, livestock and crops.
Biosecurity deters deliberate misuse of biological agents, while biosafety prevents accidental leaks. With dual-use biotech spreading and non-state interest in toxins reported, India’s multi-agency system needs tighter coordination, clearer lab oversight, and stronger surge response.
PUBLISHED DECEMBER 16, 2025
UPDATED JULY 15, 2026
6 MIN READ416 VIEWS
SHARE THIS ARTICLE
India’s biosecurity gap in the age of new biotechnology
India’s biosecurity gap in the age of new biotechnology

India’s exposure to biological risk is no longer limited to natural outbreaks. New-age biotechnology is making it cheaper to study pathogens, easier to modify biological systems, and faster to scale life-science experiments. This has delivered enormous benefits in medicine and agriculture, but it has also widened the “dual-use” problem: tools built for legitimate research can be misused by malicious actors. In that context, biosecurity is not a niche technical domain; it is a core layer of national resilience.

What biosecurity means, and what it does not

Biosecurity

Biosecurity is the set of systems meant to deter and detect the intentional misuse of biological agents, toxins, or enabling technologies. It includes lab security, controls on access to dangerous pathogens, early detection of unusual outbreaks, and the capacity to contain an event that may be deliberate.

Biosafety

Biosafety focuses on preventing accidental release or exposure—safe lab practices, containment protocols, and operational discipline. Strong biosafety reduces accidents, and that directly strengthens biosecurity, because accidental leaks and deliberate misuse can look similar at first.

The global frame: the Biological Weapons Convention

What the BWC does

The Biological Weapons Convention (in force since 1975) is the foundational international treaty prohibiting the development, production and stockpiling of biological weapons, and requiring destruction of existing stockpiles.

The structural weakness

Unlike some other arms control regimes, the BWC has historically faced challenges around verification and enforcement. In practice, compliance relies heavily on national implementation: domestic laws, oversight capacity, and the ability to investigate suspicious activity.

Why India’s biosecurity challenge is distinct

Geography and cross-border exposure

India’s size, porous ecological interfaces, and high connectivity increase vulnerability to transboundary biological risks—whether human, animal or plant.

Population density and urban systems

A biological incident—natural or deliberate—scales faster in dense settlements, high-mobility corridors, and overburdened primary health networks. Speed of detection often determines the scale of harm.

Agriculture and livestock dependency

India’s food security and rural livelihoods can be disrupted by disease events affecting crops or animals. A plant or livestock shock can cascade into inflation, income stress and political instability.

Are non-state actors pursuing biological tools?

The uncomfortable answer: interest exists

Open reporting has flagged instances where toxins such as ricin were allegedly prepared for potential misuse. Such cases underline that bio-risk is not only about state programmes. Non-state actors may pursue lower-complexity biological or toxin routes because they are easier to conceal, cheaper than conventional weapons programmes, and can create fear disproportionate to scale.

The real risk is “asymmetric impact”

Even limited incidents can generate outsized consequences: panic, health-system overload, economic disruption, and community mistrust—especially if attribution is unclear.

Where India stands today: multiple agencies, uneven integration

India already has a spread of institutions handling pieces of bio-risk:

  • public health surveillance and outbreak response capacity,

  • research governance and lab safety frameworks,

  • animal health monitoring for transboundary diseases,

  • plant quarantine systems regulating agricultural movement,

  • disaster-management guidelines for biological emergencies.

It also has legal instruments relevant to bio-risk governance, including frameworks governing hazardous microorganisms/GMOs and laws criminalising unlawful WMD-related activity.

The core issue is not absence of tools, but fragmentation. A multi-agency ecosystem can work only if roles are clearly mapped, data flows are fast, and accountability is unambiguous during a crisis.

The risks ahead

Dual-use acceleration

Gene editing, synthetic biology, and automation can reduce barriers to biological experimentation. This increases the premium on oversight, screening, and secure research culture.

Attribution and trust deficit

Biological events are hard to attribute quickly. When the public is uncertain whether an outbreak is natural or deliberate, rumours spread faster than facts—damaging compliance with health advisories.

Response capacity as the limiting factor

Analyses such as the Global Health Security Index have noted that detection metrics may improve while response capacity lags. In practice, response is where the toughest stress appears: surge staffing, isolation capacity, risk communication, and coordination across districts and ministries.

What an upgraded biosecurity posture would look like

A unified national biosecurity framework

A single, clearly articulated national framework should define:

  • who leads during different kinds of biological events,

  • how health, agriculture and security systems coordinate,

  • how labs are regulated and audited,

  • how intelligence and public health share signals lawfully.

One Health as an operating model, not a slogan

Human health, animal health and plant health must be treated as one ecosystem, with shared surveillance triggers and joint preparedness exercises.

Stronger lab governance without stifling science

The goal is not to slow innovation, but to harden it:

  • consistent biosafety and biosecurity audits,

  • better training and certification,

  • secure access controls for high-risk materials,

  • stronger incident reporting culture.

Surge readiness and public communication

Preparedness must include scalable response: hospital surge protocols, district-level drills, and trusted communication that can counter misinformation early.

Conclusion

India does need to upgrade its biosecurity measures—not because a specific attack is inevitable, but because the cost of being unprepared is catastrophic and the technological landscape is shifting quickly. The country already has many institutions and laws in place. The next leap is integration: a unified framework that connects laboratories, surveillance systems, agricultural defences and emergency response into one coherent national capability.

Source credits: Author-provided article text shared by the user; publicly known treaty framework of the Biological Weapons Convention; India’s published legal and institutional architecture on biosafety, WMD prohibition and biological disaster management .


Stay Informed

Get our weekly digest of the most important news and analysis delivered to your inbox.

Trending

Loading trending articles...

Latest News

Loading latest articles...

Categories

Loading categories...

About the Author

Raman sandhu

Raman sandhu

Editor At Large

Raman leads editorial direction and long-form analysis at The Upsc Times, bringing a clarity-first approach to governance, law, and public policy. He blends pro

Related Articles

ADVERTISEMENT
India’s biosecurity gap in the age of new biotechnology | The Upsc Times